Brief: Bone Therapeutics Gets EUR 1.0 Mln To Advance JTA-004 Phase III Knee Osteoarthritis Study

Biosenic SA

13/08/2020 06:09

Aug 13 (Reuters) - Bone Therapeutics SA  BOTHE.BR :
    * REG-BONE THERAPEUTICS RECEIVES EUR 1.0 MILLION TO ADVANCE ONGOING JTA-004 PHASE III KNEE
OSTEOARTHRITIS STUDY
    * THIS FUNDING WILL PROVIDE FURTHER FINANCIAL SUPPORT TO BONE THERAPEUTICS, IN ADDITION TO
RECENT
FINANCING, TO ADVANCE ITS CURRENT PIVOTAL PHASE III CLINICAL STUDY WITH ENRICHED PROTEIN
SOLUTION, JTA-004

Source text for Eikon:  ID:nGNE8xhz6q 
Further company coverage:  BOTHE.BR 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))